Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes*,**
References (41)
- et al.
Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus
Metabolism
(1997) - et al.
Isolation of methylglyoxal synthase from goat liver
J Biol Chem
(1981) - et al.
Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes
J Biol Chem
(1985) - et al.
The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery
Biochem Pharmacol
(1992) - et al.
Binding and modification of proteins by methylglyoxal under physiological conditions
J Biol Chem
(1994) - et al.
Role of the Maillard reaction in aging of tissue proteins
J Biol Chem
(1998) - et al.
Methylglyoxal-modified arginine residues—A signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells
Biochim Biophys Acta
(1997) Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system: Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors
Chem-Biol Interact
(1998)- et al.
The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins
Biochem Pharm
(1994) - et al.
Immunochemical detection of advanced glycosylation end products in vivo
J Biol Chem
(1992)
Immunological evidence for methylglyoxal-derived modifications in vivo
J Biol Chem
(1998)
Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes
FEBS Letters
(1997)
Synthesis and secretion of tumour necrosis factor–α by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts
Immunol Lett
(1997)
Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications
N Engl J Med
(1987)
Role of oxidative stress in diabetic complications. A new perspective on an old paradigm
Diabetes
(1999)
Protein kinase C activation and the development of diabetic complications
Diabetes
(1998)
Glycation and diabetic complications
Diabetes
(1994)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
N Engl J Med
(1998)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
BMJ
(2000)
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
N Engl J Med
(1988)
Cited by (160)
Mechanism of peroxidasin inactivation in hyperglycemia: Heme damage by reactive oxygen species
2023, Biochemical and Biophysical Research CommunicationsIdentification of biomarkers in diabetic nails by Raman spectroscopy
2023, Clinica Chimica ActaMethylglyoxal-derived hemoglobin advanced glycation end products induce apoptosis and oxidative stress in human umbilical vein endothelial cells
2021, International Journal of Biological MacromoleculesLong-term methylglyoxal intake aggravates murine Th2-mediated airway eosinophil infiltration
2020, International ImmunopharmacologyGinsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway
2019, Molecular and Cellular Probes
- *
Supported by grants from the Norwegian Foundation for Health and Rehabilitation, Aker Diabetes Research Fund, and the Norwegian Diabetes Association, and in part by a grant from the National Institutes of Health, Bethesda, MD.
- **
Address reprint requestst to Bente K. Kilhovd, MD, Aker Diabetes Research Centre, Aker University Hospital, N-0514 Oslo, Norway.
Copyright © 2003 Published by Elsevier Inc.